Stephen Willey
Stock Analyst at Stifel
(3.81)
# 749
Out of 5,032 analysts
122
Total ratings
44.94%
Success rate
11.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACLX Arcellx | Reinstates: Buy | $129 | $86.95 | +48.36% | 1 | Oct 16, 2025 | |
| INCY Incyte | Maintains: Buy | $110 → $115 | $87.57 | +31.32% | 7 | Sep 22, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $2.96 | +204.05% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $165.76 | -12.52% | 8 | Aug 14, 2025 | |
| NKTX Nkarta | Maintains: Buy | $14 → $12 | $2.30 | +421.74% | 4 | Aug 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $8 → $7 | $5.59 | +25.22% | 7 | Aug 8, 2025 | |
| EXEL Exelixis | Maintains: Hold | $38 → $41 | $39.25 | +4.46% | 19 | Jul 29, 2025 | |
| CELC Celcuity | Reinstates: Buy | $30 | $51.96 | -42.26% | 1 | Jul 1, 2025 | |
| CBIO Crescent Biopharma | Initiates: Buy | $28 | $12.54 | +123.29% | 1 | Jun 25, 2025 | |
| MGNX MacroGenics | Maintains: Hold | $6 → $5 | $1.65 | +203.03% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $5.75 | +247.78% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $35 | $9.84 | +255.69% | 5 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $29.00 | +244.83% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.20 | +233.33% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $18.40 | +52.17% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $18.25 | +157.53% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.80 | +402.39% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.88 | +113.33% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $41.63 | +48.93% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.26 | +111.27% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.66 | +622.89% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $2.35 | +12,155.32% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.21 | +850.23% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.42 | +181.69% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $481.67 | -74.46% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $73.09 | -35.70% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $53.29 | +104.54% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $17.27 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $8.75 | +162.86% | 5 | Feb 7, 2018 |
Arcellx
Oct 16, 2025
Reinstates: Buy
Price Target: $129
Current: $86.95
Upside: +48.36%
Incyte
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $115
Current: $87.57
Upside: +31.32%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $2.96
Upside: +204.05%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $165.76
Upside: -12.52%
Nkarta
Aug 14, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.30
Upside: +421.74%
AbCellera Biologics
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $5.59
Upside: +25.22%
Exelixis
Jul 29, 2025
Maintains: Hold
Price Target: $38 → $41
Current: $39.25
Upside: +4.46%
Celcuity
Jul 1, 2025
Reinstates: Buy
Price Target: $30
Current: $51.96
Upside: -42.26%
Crescent Biopharma
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $12.54
Upside: +123.29%
MacroGenics
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.65
Upside: +203.03%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.75
Upside: +247.78%
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $9.84
Upside: +255.69%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $29.00
Upside: +244.83%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.20
Upside: +233.33%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $18.40
Upside: +52.17%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $18.25
Upside: +157.53%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.80
Upside: +402.39%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.88
Upside: +113.33%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $41.63
Upside: +48.93%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $4.26
Upside: +111.27%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.66
Upside: +622.89%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $2.35
Upside: +12,155.32%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.21
Upside: +850.23%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.42
Upside: +181.69%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $481.67
Upside: -74.46%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $73.09
Upside: -35.70%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $53.29
Upside: +104.54%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $17.27
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $8.75
Upside: +162.86%